• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form EFFECT filed by Aspire Biopharma Holdings Inc.

    4/22/25 12:15:15 AM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ASBP alert in real time by email
    Notice of Effectiveness
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    Notice of Effectiveness
    Effectiveness Date: April 21, 2025 4:30 P.M.
    Form: S-1
    CIK: 0001847345
    Company Name: Aspire Biopharma Holdings, Inc.
    File Number: 333-286444
    Get the next $ASBP alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $ASBP

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ASBP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: Director Fell Donald G. bought $7,800 worth of shares (20,000 units at $0.39) (SEC Form 4)

      4/A - Aspire Biopharma Holdings, Inc. (0001847345) (Issuer)

      6/10/25 5:25:23 PM ET
      $ASBP
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Fell Donald G. increased direct ownership by 5% to 20,000 units (SEC Form 4)

      4 - Aspire Biopharma Holdings, Inc. (0001847345) (Issuer)

      6/6/25 5:00:59 PM ET
      $ASBP
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ASBP
    SEC Filings

    See more
    • Aspire Biopharma Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

      6/18/25 5:29:15 PM ET
      $ASBP
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Aspire Biopharma Holdings Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

      6/10/25 8:30:38 AM ET
      $ASBP
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form EFFECT filed by Aspire Biopharma Holdings Inc.

      EFFECT - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

      5/30/25 12:15:15 AM ET
      $ASBP
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ASBP
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Presenting on Emerging Growth Conference 81 Day 2 on April 17; Register to live stream

      MIAMI, April 16, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 80th Emerging Growth Conference on April 16 & 17, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: [email protected] For updates, follow us on Twitter Day 1 - TodayApril 16, 2025 9:00Virtual Lobby opens.Register for the Conference. If you already registered, go back to t

      4/16/25 7:00:00 AM ET
      $ASBP
      $BENF
      $BNZI
      $CIA
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Finance: Consumer Services
      Finance
    • Presenting on Emerging Growth Conference 81 Day 1 on April 16; Register to live stream

      MIAMI, April 15, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 81th Emerging Growth Conference on April 16 & 17, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: [email protected] For updates, follow us on Twitter Day 1April 16, 2025 9:00Virtual Lobby opens.Register for the Conference. If you already register

      4/15/25 7:00:00 AM ET
      $ASBP
      $BENF
      $BNZI
      $CIA
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Finance: Consumer Services
      Finance

    $ASBP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: Director Fell Donald G. bought $7,800 worth of shares (20,000 units at $0.39) (SEC Form 4)

      4/A - Aspire Biopharma Holdings, Inc. (0001847345) (Issuer)

      6/10/25 5:25:23 PM ET
      $ASBP
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Fell Donald G. increased direct ownership by 5% to 20,000 units (SEC Form 4)

      4 - Aspire Biopharma Holdings, Inc. (0001847345) (Issuer)

      6/6/25 5:00:59 PM ET
      $ASBP
      Biotechnology: Pharmaceutical Preparations
      Health Care